Momentis Surgical Receives FDA 510(k) Clearance for Second Generation Anovo® Robotic Platform, Introducing Haptic Feedback and Dual-Mode Articulation
November 11, 2024
TEL AVIV, Israel and FORT LAUDERDALE, Fla., Nov. 11, 2024 /PRNewswire/ — Momentis Surgical Ltd., a leader in robotic-assisted surgical innovation, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for its second-generation Anovo® robotic surgical platform.
